Please assess the completion status of the following clinical trial:

Trial Title: NEUROTOX: Two Dosages of Type A Botulinic Toxin in Neurogenic Overactive Bladder

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Neurogenic urinary incontinence with urodynamic overactivity resistant to anticholinergic~Exclusion Criteria:~* Pregnancy~* Bladder cancer~* Symptomatic urinary infection

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).